284 related articles for article (PubMed ID: 16498507)
1. The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosis.
Verma S; Szmitko PE
Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):12B-17B. PubMed ID: 16498507
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and atherosclerosis.
Soskić SS; Dobutović BD; Sudar EM; Obradović MM; Nikolić DM; Zarić BL; Stojanović SD; Stokić EJ; Mikhailidis DP; Isenović ER
Angiology; 2011 Oct; 62(7):523-34. PubMed ID: 21467121
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis and cardiovascular risk reduction with PPAR agonists.
Kuusisto J; Andrulionyte L; Laakso M
Curr Atheroscler Rep; 2007 Oct; 9(4):274-80. PubMed ID: 18173954
[TBL] [Abstract][Full Text] [Related]
4. The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.
Escandon P; Vasini B; Whelchel AE; Nicholas SE; Matlock HG; Ma JX; Karamichos D
Exp Eye Res; 2021 Jul; 208():108617. PubMed ID: 34010603
[TBL] [Abstract][Full Text] [Related]
5. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
6. PPARs and diabetes-associated atherosclerosis.
Calkin AC; Jandeleit-Dahm KA; Sebekova E; Allen TJ; Mizrahi J; Cooper ME; Tikellis C
Curr Pharm Des; 2007; 13(26):2736-41. PubMed ID: 17897018
[TBL] [Abstract][Full Text] [Related]
7. PPARs as therapeutic targets in cardiovascular disease.
van Bilsen M; van Nieuwenhoven FA
Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178
[TBL] [Abstract][Full Text] [Related]
8. Direct antiatherosclerotic effects of PPAR agonists.
Jandeleit-Dahm KA; Calkin A; Tikellis C; Thomas M
Curr Opin Lipidol; 2009 Feb; 20(1):24-9. PubMed ID: 19133407
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.
Gouni-Berthold I; Krone W
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):513-23. PubMed ID: 16503871
[TBL] [Abstract][Full Text] [Related]
10. [PPARs: the role in glucose and lipid homeostasis, insulin resistance and atherosclerosis].
Hrebícek J
Cesk Fysiol; 2004; 53(1):4-16. PubMed ID: 15702884
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
12. PPAR agonists and the metabolic syndrome.
Staels B
Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis.
Li AC; Palinski W
Annu Rev Pharmacol Toxicol; 2006; 46():1-39. PubMed ID: 16402897
[TBL] [Abstract][Full Text] [Related]
14. [Peroxisome proliferator activated receptors (PPAR) and insulin sensitivity: experimental studies].
Haluzík MM; Haluzík M
Cesk Fysiol; 2006; 55(4):163-8. PubMed ID: 17685022
[TBL] [Abstract][Full Text] [Related]
15. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
Cheang WS; Tian XY; Wong WT; Huang Y
Br J Pharmacol; 2015 Dec; 172(23):5512-22. PubMed ID: 25438608
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis; cell biology and lipoproteins: lipid metabolism, eicosanoids, peroxisome proliferator activated receptors and the atherogenic process.
Davidson J; Rotondo D
Curr Opin Lipidol; 2006 Aug; 17(4):489-91. PubMed ID: 16832175
[No Abstract] [Full Text] [Related]
17. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
18. [PPAR family and its relationship to metabolic syndrome].
Zhang XY; Chen LH; Guan YF
Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336
[TBL] [Abstract][Full Text] [Related]
19. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
Menendez-Gutierrez MP; Roszer T; Ricote M
Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
